Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Retinal imaging can estimate biological age and flag systemic disease risk, but new research shows the "retinal age gap" isn't reliable enough yet for clinical monitoring. Studies found the biomarker's accuracy varies with age and is inconsistent when tracking the same person over time. Experts say more work is needed before it becomes a clinically actionable tool.
A photo of the back of your eye can estimate how old your body really is — and researchers are working hard to figure out how useful that actually is. The "retinal age gap," the difference between your predicted biological age from a retinal scan and your actual age, has been linked to conditions like cardiovascular disease, diabetes, stroke, and Parkinson's disease. AI-powered tools to measure it are already available to consumers, no doctor required.
But new research presented at the Euretina congress in Vienna urges caution. Studies from Moorfields Eye Hospital and University College London found that while the retinal age gap is significantly elevated in many systemic health conditions, its reliability breaks down with age — and crucially, it doesn't track consistently within the same individual over time. Across 31 different health conditions, longitudinal validation largely fell short.
Key Takeaways:
Why it matters: Until the retinal age gap can reliably track disease progression in individuals over time, it remains a research tool rather than a clinical one — and consumer-facing AI products may be getting ahead of the science.